U.S. federal trademark · Serial No. 88916847
Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.